• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/05/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the balloon ruptured.This ranger global dcb otw 7.0 x 100mm, 135cm was selected for use in an endovascular therapy procedure.The lesion was located in the superficial femoral artery (sfa) and was 99% stenosed, mildly tortuous, and moderately calcified.It was noted the balloon ruptured during the first inflation at 14 atmospheres for 30 seconds.The device was able to be removed, the procedure was completed with a different ranger balloon, and there was no patient injury.The device is expected to be returned.
 
Additional Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, this ranger global dcb otw 7.0 x 100mm, 135cm was visually and microscopically examined.Visual examination of the outer shaft, inner shaft, balloon, and tip revealed a longitudinal tear to the balloon 70 mm from the tip and was approximately 33 mm long.Microscopic examination revealed no additional damages, and inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there was a longitudinal tear in the balloon.
 
Event or Problem Description
It was reported that the balloon ruptured.This ranger global dcb otw 7.0 x 100mm, 135cm was selected for use in an endovascular therapy procedure.The lesion was located in the superficial femoral artery (sfa) and was 99% stenosed, mildly tortuous, and moderately calcified.It was noted the balloon ruptured during the first inflation at 14 atmospheres for 30 seconds.The device was able to be removed, the procedure was completed with a different ranger balloon, and there was no patient injury.The device is expected to be returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16820268
Report Number2124215-2023-16174
Device Sequence Number17916319
Product Code ONU
UDI-Device Identifier08714729976301
UDI-Public08714729976301
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/30/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number04611H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/20/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/05/2023
Supplement Date Received by Manufacturer04/27/2023
Initial Report FDA Received Date04/26/2023
Supplement Report FDA Received Date05/02/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/31/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-